The Biotech(IBB) rout is far from over. It could be 4-5 years before markets willingly pay top dollar for drug stocks. For value investors, waiting is the strategy that pays off and for gamblers who bought at the peak, they will have to wait a long time to break-even.
Biotech Picks for May, 2018
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться